Korro Bio, Inc. (KRRO)
8.23
+0.33
(+4.18%)
USD |
NASDAQ |
Dec 12, 16:00
8.28
+0.05
(+0.61%)
After-Hours: 20:00
Korro Bio Total Liabilities (Quarterly): 62.52M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Gilead Sciences, Inc. | 37.08B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Nutriband, Inc. | 0.8702M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 161.55M |
| Shareholders Equity (Quarterly) | 99.03M |
| Debt to Equity Ratio | 0.451 |
| Current Ratio | 6.710 |
| Net Debt Paydown Yield | -0.28% |